Teva Gets Full FDA Approval for Leukemia Injection

Teva Pharmaceutical Industries announced last week that the U.S. FDA granted full approval of Synribo to treat chronic myeloid leukemia.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news